威尼斯人
髓系白血病
医学
肿瘤科
危险分层
内科学
低甲基化剂
白血病
重症监护医学
基因
生物
遗传学
DNA甲基化
慢性淋巴细胞白血病
基因表达
作者
Curtis A. Lachowiez,Vishvaas Ravikumar,Jad Othman,Jenny O’Nions,D. Peters,Christine M. McMahon,Ronan Swords,Rachel C. Cook,Jennifer N. Saultz,Jeffrey W. Tyner,Richard Dillon,Joshua F. Zeidner,Daniel A. Pollyea
出处
期刊:Blood
[American Society of Hematology]
日期:2024-11-01
标识
DOI:10.1182/blood.2024026925
摘要
The ELN 2024 risk-stratification guidelines for patients with acute myeloid leukemia receiving hypomethylating agents combined with venetoclax were recently published. This analysis demonstrates re-classification and incorporation of new gene mutations in the present model can further improve and individualize prognostication.
科研通智能强力驱动
Strongly Powered by AbleSci AI